Solar Farm Thailand Explores Setting Up In-House Cannabis Testing Lab

October 2025 — Following its recent push to help medical buyers improve testing turnaround times, Solar Farm Thailand has begun exploring the next step in its quality-control journey: establishing an in-house cannabis testing lab.

The initiative aims to strengthen GACP-aligned quality assurance and reduce dependence on external laboratory timelines, allowing faster internal verification of potency and purity before official certification.

In Thailand’s evolving medical cannabis market, testing remains one of the most time-sensitive stages of production. Each batch must pass third-party analysis for cannabinoid potency, microbial safety, and heavy metals before it can be sold or transferred to licensed buyers.

While these external checks are mandatory and vital for compliance, Solar Farm Thailand believes that having an in-house pre-testing system will help ensure that every sample sent for certification already meets the expected quality range.

“Our goal isn’t to replace accredited labs,” Song, CEO of Solar Farm Thailand explained. “It’s about tightening our internal quality control loop so we know exactly what we’re sending out — and can give buyers more confidence from day one.”

The Solar Farm Thailand quality team has been researching several HPLC systems (High-Performance Liquid Chromatography) currently used by European and Asia-Pacific testing labs. HPLC is the industry standard for analyzing cannabinoids such as THC, CBD, and CBG, providing high-precision results without requiring full decarboxylation or destruction of the sample.

By identifying models that balance accuracy, support availability, and operational simplicity, Solar Farm Thailand hopes to integrate lab-grade analysis directly within its controlled indoor cultivation facility.

“We’re not just looking for the most advanced equipment,” the spokesperson added. “We’re looking for the most practical solution for our environment — one that our trained QC team can operate efficiently while staying aligned with GACP requirements.”

Adding in-house HPLC testing would allow Solar Farm Thailand to:
Verify cannabinoid levels before sending samples for official certification.

• Monitor potency trends throughout harvests and across phenotypes.
• Cross-check external lab results for greater consistency and transparency.
• Optimize post-harvest processes, such as drying and curing, based on live data.

These capabilities would make Solar Farm Thailand one of the few cannabis facilities in the country to combine GACP-compliant cultivation with near-real-time analytical feedback. The result: faster, more consistent quality control and tighter batch-to-batch precision for medical wholesale in Thailand.

Since launching its first production site Solar Farm Thailand has built its reputation on traceability, sustainability, and transparency. Every harvest follows documented SOPs, and each lot includes full trace records from mother plant to final batch.

With in-house analytical capability, the company aims to add another layer of transparency — providing internal pre-COA data that can help buyers make informed procurement decisions even before external certificates are finalized.

“Medical buyers often tell us they value predictability,” the team said. “If we can provide early cannabinoid data verified through our own QC system, it helps them plan their supply chains better. That’s the kind of trust we want to build.”

Solar Farm Thailand’s move toward internal testing reflects a broader trend across the global medical cannabis industry, where producers are investing in analytical capability to meet both domestic and export expectations.

By aligning these efforts with Thai and EU GACP principles, Solar Farm Thailand continues to set benchmarks for medical cannabis Thailand — emphasizing measurable quality, sustainable cultivation, and operational transparency.

As Thailand’s medical market grows and the regulatory framework evolves, having robust, science-driven quality systems in place will become a defining factor for long-term credibility.

The Solar Farm Thailand team is currently in the evaluation and feasibility phase, comparing HPLC systems, training requirements, and integration options for its controlled facility. Once validated, the company plans to conduct pilot testing alongside official lab submissions to establish data correlation and accuracy.

“Our goal is simple,” Song, CEO of Solar Farm Thailand summarized. “We want to give medical buyers confidence that every flower, oil, or extract from Solar Farm meets the same high standard — verified in-house, confirmed externally, and traceable all the way through.”